Tumor Mutational Load, CD8+T Cells, Expression of PD-L1 and HLA Class I to Guide Immunotherapy Decisions

被引：1
|
作者：
Hurkmans, D. [1 ]
Kuipers, M. [2 ]
Smit, J. [2 ]
Van Marion, R. [3 ]
Mathijssen, R. [4 ]
Postmus, P. [2 ]
Hiemstra, P. [2 ]
Aerts, J. [1 ]
Von der Thusen, J. [3 ]
Van der Burg, S. [5 ]
机构：
[1] Erasmus Univ, Med Ctr, Pulmonol, Rotterdam, Netherlands
[2] Leiden Univ, Med Ctr, Pulmonol, Leiden, Netherlands
[3] Erasmus Univ, Med Ctr, Pathol, Rotterdam, Netherlands
[4] Erasmus Univ, Med Ctr, Med Oncol, Rotterdam, Netherlands
[5] Leiden Univ, Med Ctr, Med Oncol, Leiden, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
immune checkpoint inhibitor; NSCLC; predictive biomarkers;
D O I：
10.1016/j.jtho.2019.08.1552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-47
引用
收藏
页码：S726 / S726
页数：1
相关论文
共 50 条
  • [1] Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
    Daan P. Hurkmans
    Merian E. Kuipers
    Jasper Smit
    Ronald van Marion
    Ron H. J. Mathijssen
    Piet E. Postmus
    Pieter S. Hiemstra
    Joachim G. J. V. Aerts
    Jan H. von der Thüsen
    Sjoerd H. van der Burg
    Cancer Immunology, Immunotherapy, 2020, 69 : 771 - 777
  • [2] Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
    Hurkmans, Daan P.
    Kuipers, Merian E.
    Smit, Jasper
    van Marion, Ronald
    Mathijssen, Ron H. J.
    Postmus, Piet E.
    Hiemstra, Pieter S.
    Aerts, Joachim G. J. V.
    von der Thusen, Jan H.
    van der Burg, Sjoerd H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (05) : 771 - 777
  • [3] Combined assessment of tumour mutational load, CD8+T cell infiltration, and expression of PD-L1 and HLA class I in small biopsy specimens to predict immunotherapy response in non-small cell lung cancer
    Hurkmans, D.
    Kuipers, M.
    Smit, J.
    Mathijssen, R.
    Postmus, P.
    Hiemstra, P.
    Aerts, J.
    van Marion, R.
    van der Burg, S.
    von der Thusen, J.
    VIRCHOWS ARCHIV, 2019, 475 : S41 - S41
  • [4] The Effects of Epigenetic Modifiers on PD-L1 and HLA Class I Expression on Tumor Cells
    Maini, Trisha
    Sternberg, Lauren
    O'Donnell, Robert W.
    FASEB JOURNAL, 2019, 33
  • [5] Assessment of Tumoral PD-L1 Expression and Intratumoral CD8+T Cells in Urothelial Carcinoma
    Faraj, Sheila F.
    Munari, Enrico
    Guner, Gunes
    Taube, Janis
    Anders, Robert
    Hicks, Jessica
    Meeker, Alan
    Schoenberg, Mark
    Bivalacqua, Trinity
    Drake, Charles
    Netto, George J.
    UROLOGY, 2015, 85 (03) : 703.e1 - 703.e6
  • [6] PD-L1 Expression and CD8+T Cell Infiltration Associate with the Prognosis of Pulmonary Neuroendocrine Tumor
    Wang, H.
    Li, Z.
    Sun, W.
    Yang, X.
    Zhou, L.
    Lin, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1998 - S1998
  • [7] Infiltrating CD8+T-cells and PD-L1 expression as indicators for immunotherapy in sinonasal cancer
    Lopez, F.
    Garcia-Marin, R.
    Suarez-Fernandez, L.
    Naves-Cabal, V.
    Riobello, C.
    Reda, S.
    Hermsen, M.
    Llorente, J. L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 95 - 95
  • [8] Frequency changes in HLA-I alleles: A marker to guide immunotherapy in lung adenocarcinoma patients and its relationship with tumor mutational burden and PD-L1 expression
    Wu, Xuanpeng
    Wang, Hao
    Xue, Fei
    Jiang, Tao
    Chen, Nanzheng
    Wang, Tianju
    Zhang, Yong
    Zhang, Guangjian
    Fu, Junke
    Wu, Qifei
    THORACIC CANCER, 2023, 14 (20) : 1932 - 1940
  • [9] Effects of tumor-infiltrating CD8+T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy
    Okita, Riki
    Mimura-Kimura, Yuka
    Kawamoto, Nobutaka
    Yamamoto, Naoki
    Umeda, Masashi
    Okada, Masanori
    Inokawa, Hidetoshi
    Mimura, Yusuke
    Murakami, Tomoyuki
    Nakata, Masao
    Okabe, Kazunori
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (04) : 865 - 879
  • [10] IFNγ-mediated stimulation of PD-L1 expression on exosomes in urological malignancies and their effect on CD8+T cells
    Jaschkowitz, G.
    Haid, M.
    Himbert, D.
    Zaccagnino, A.
    Stoeckle, M.
    Noessner, E.
    Junker, K.
    Zeuschner, P.
    EUROPEAN UROLOGY, 2023, 83
12345